SEC CIK 1061632
AUSTIN ROXANNE S
Reported ownership across 5 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| CRWDview stock → | 77,040 | 2026-09-14 |
| ABTview stock → | 41,542 | 2021-04-23 |
| ABBVview stock → | 39,576 | 2026-05-08 |
| TGTview stock → | 34,838 | 2020-06-04 |
| TDYview stock → | 7,305 | 2020-06-05 |
Position History — TGT
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — TGT
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2020-06-04 | Open-market sale | 10,000 | $122.01 | 34,838 |
| 2020-06-02 | Option exercise (derivative) | 7,415 | $0.00 | 0 |
| 2020-06-02 | Open-market sale | 7,415 | $120.01 | 44,838 |
| 2020-06-02 | Option exercise | 7,415 | $60.48 | 52,253 |
| 2020-05-29 | Option exercise (derivative) | 4,109 | $0.00 | 0 |
| 2020-05-29 | Option exercise | 4,109 | $55.46 | 48,947 |
| 2020-05-29 | Open-market sale | 4,109 | $120.04 | 44,838 |
| 2020-03-11 | Grant / award | 1,711 | $0.00 | 44,838 |
| 2019-06-13 | Option exercise (derivative) | 4,163 | $0.00 | 0 |
| 2019-06-13 | Open-market sale | 4,163 | $89.00 | 42,532 |
| 2019-06-13 | Option exercise | 4,163 | $49.41 | 46,695 |
| 2019-03-13 | Grant / award | 2,338 | $0.00 | 42,287 |
| 2018-03-14 | Grant / award | 2,538 | $0.00 | 38,951 |
| 2017-12-15 | Option exercise (derivative) | 4,705 | $0.00 | 0 |
| 2017-12-15 | Option exercise | 4,705 | $48.89 | 40,882 |
| 2017-12-15 | Open-market sale | 4,705 | $62.61 | 36,177 |
| 2017-01-11 | Grant / award | 2,377 | $0.00 | 35,080 |
| 2016-12-02 | Option exercise (derivative) | 3,957 | $0.00 | 0 |
| 2016-12-02 | Option exercise | 3,957 | $58.13 | 36,479 |
| 2016-12-02 | Open-market sale | 3,957 | $77.87 | 32,522 |
| 2016-01-13 | Grant / award | 2,349 | $0.00 | 31,976 |
| 2016-01-07 | Option exercise (derivative) | 3,706 | $0.00 | 0 |
| 2016-01-07 | Open-market sale | 3,706 | $75.03 | 29,627 |
| 2016-01-07 | Option exercise | 3,706 | $53.98 | 33,333 |
| 2015-03-20 | Option exercise (derivative) | 6,365 | $0.00 | 0 |
| 2015-03-20 | Open-market sale | 9,081 | $81.66 | 29,195 |
| 2015-03-20 | Option exercise | 6,365 | $48.88 | 38,276 |
| 2015-01-14 | Grant / award | 2,292 | $0.00 | 31,778 |
| 2015-01-06 | Option exercise (derivative) | 8,093 | $0.00 | 0 |
| 2015-01-06 | Tax withholding | 5,377 | $74.41 | 29,486 |
| 2015-01-06 | Option exercise | 8,093 | $49.43 | 34,863 |
| 2014-06-02 | Open-market buy | 10,000 | $56.78 | 26,375 |
| 2014-01-08 | Grant / award | 2,715 | $0.00 | 16,256 |
| 2013-01-09 | Grant / award (derivative) | 7,415 | $0.00 | 7,415 |
| 2013-01-09 | Grant / award | 1,489 | $0.00 | 13,204 |
| 2012-06-08 | Option exercise (derivative) | 10,458 | $0.00 | 0 |
| 2012-06-08 | Option exercise | 6,391 | $33.80 | 28,362 |
| 2012-06-08 | Open-market sale | 16,849 | $58.75 | 11,513 |
| 2012-06-08 | Option exercise | 10,458 | $38.25 | 21,971 |
| 2012-05-31 | Option exercise (derivative) | 13,219 | $0.00 | 0 |
| 2012-05-31 | Option exercise | 13,219 | $30.26 | 24,732 |
| 2012-05-31 | Open-market sale | 13,219 | $58.25 | 11,513 |
| 2012-01-11 | Grant / award (derivative) | 6,365 | $0.00 | 6,365 |
| 2012-01-11 | Grant / award | 1,842 | $0.00 | 11,450 |
| 2011-01-12 | Grant / award (derivative) | 4,109 | $0.00 | 4,109 |
| 2011-01-12 | Grant / award | 1,353 | $0.00 | 9,386 |
| 2010-12-10 | Open-market sale | 2,388 | $58.95 | 7,996 |
| 2010-01-13 | Grant / award (derivative) | 4,163 | $0.00 | 4,163 |
| 2010-01-13 | Grant / award | 1,518 | $0.00 | 10,290 |
| 2009-01-14 | Grant / award (derivative) | 6,391 | $0.00 | 6,391 |
| 2009-01-14 | Grant / award | 2,219 | $0.00 | 8,656 |
| 2008-06-11 | Grant / award | 1,440 | $0.00 | 6,407 |
| 2008-01-09 | Grant / award (derivative) | 4,705 | $0.00 | 4,705 |
| 2007-06-13 | Grant / award | 1,189 | $0.00 | 4,940 |
| 2007-01-10 | Grant / award (derivative) | 3,957 | $0.00 | 3,957 |
| 2006-06-14 | Grant / award | 1,350 | $0.00 | 3,738 |
| 2006-01-11 | Grant / award (derivative) | 3,706 | $0.00 | 3,706 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.